Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- Institution
- Publication
- Publication Type
Articles 1 - 7 of 7
Full-Text Articles in Law
Enablement In Biotechnology Cases After In Re Goodman, John C. Todaro
Enablement In Biotechnology Cases After In Re Goodman, John C. Todaro
Fordham Intellectual Property, Media and Entertainment Law Journal
No abstract provided.
Product-By-Process Patent Claims: Majority Of The Court Of Appeals For The Federal Circuit Forgets Purpose Of The Patent Act, Mark D. Passler
Product-By-Process Patent Claims: Majority Of The Court Of Appeals For The Federal Circuit Forgets Purpose Of The Patent Act, Mark D. Passler
University of Miami Law Review
No abstract provided.
Environmentally Dependent Inventions And The "On Sale" And "Public Use" Bars Of § 102(B): A Proffered Solution To A Statutory Dichotomy, James A. Jorgensen
Environmentally Dependent Inventions And The "On Sale" And "Public Use" Bars Of § 102(B): A Proffered Solution To A Statutory Dichotomy, James A. Jorgensen
University of Miami Law Review
No abstract provided.
Commentary: Authority Of The Commissioner Over The Board Of Patent Appeals And Interferences, R. Carl Moy
Commentary: Authority Of The Commissioner Over The Board Of Patent Appeals And Interferences, R. Carl Moy
Faculty Scholarship
On August 3, 1992, the United States Patent and Trademark Office published a notice in the Federal Register requesting public comments on the PTO's appeal procedures. Taken in context, then, the notice can be fairly said to raise the issue whether, under the existing statute, the Board is subservient to the Commissioner. It also raises the broader question of whether such a subservient arrangement is desirable or, alternatively, whether the statute should be modified if necessary to give the Board decisional independence from the Commissioner. This Commentary is directed primarily to this latter point. In summary, it concludes that the …
Antitrust Law And Patent Misconduct In The Proprietary Drug Industry, Michael A. Sanzo
Antitrust Law And Patent Misconduct In The Proprietary Drug Industry, Michael A. Sanzo
Villanova Law Review
No abstract provided.
Worms, Mice, Cows And Pigs: The Importance Of Animal Patents In Developing Countries, Elisabeth T. Jozwiak
Worms, Mice, Cows And Pigs: The Importance Of Animal Patents In Developing Countries, Elisabeth T. Jozwiak
Northwestern Journal of International Law & Business
Transgenic animals play a large role in several critical industries: the pharmaceutical industry, the agricultural industry, farming, and medical research. As these biotechnology-oriented industries have grown, the United States and other industrialized nations have realized the importance of patent protection for genetically-engineered animals. Unfortunately, lesser-developed countries (LDCs), which can benefit the most from such industries, do not provide adequate patent protection for transgenic animals, even though patent protection for transgenic animals could ultimately lead to reduction in starvation and disease, two of the biggest problems facing many LDCs. The United States should pursue bilateral negotiations with developing countries in the …
Patents In Health Care - Subsidy And Victimisation?, Michael Henry Davis
Patents In Health Care - Subsidy And Victimisation?, Michael Henry Davis
Law Faculty Articles and Essays
In theory, a patent provides a monopoly over a product or a process in return for the disclosure of an inventive discovery. In practice, however, it is an indirect form of government intervention in healthcare which carries enormous calculable costs but whose benefits are entirely a matter of faith. It is ironic that in healthcare of all areas, where the guiding principle is the application of the scientific method, extraordinary investments are made in a system which so far has not been subjected to any scientific test.